Miltefosine for visceral leishmaniasis.
Eibl
H
H
D000981:Antiprotozoal Agents / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine